LDS/Medical Tests/FLG (filaggrin) Gene Mutation Analysis

FLG (filaggrin) Gene Mutation Analysis

The FLG gene is located at (1q21.3) and codes for the protein profilaggrin that localizes in the outermost layer of the skin. Profilaggrin is post-translationally modified to produce filaggrin, which is directly involved in epidermal development and keratinocyte integrity. Loss of function mutations in the FLG gene result in truncated profilaggrin and filaggrin production leading to compromised keratocyte development and poor epidermal integrity.

FLG mutations are associated with two major epidermal disorders: ichthyosis vulgaris and atopic dermatitis. The phenotypic characteristics of ichthyosis vulgaris include palmar hyper linearity, keratosis pilaris, and a fine scale that is most prominent over the lower abdomen, arms, and legs. Patients with atopic dermatitis manifest erythematous and intensely pruritic areas of the skin. Since the epidermis is a major barrier to infection, these conditions can result in chronic and complicated cutaneous infections. Diagnosis of these conditions can be confirmed by mutation analysis of the FLG gene.

  • As an aid in the diagnosis of ichthyosis vulgaris
  • As an aid in the diagnosis of atopic dermatitis
A positive result indicated the presence of mutations in the FLG gene thus suggestive of the risk of either disease. A negative result indicates the absence of mutations in the FLG gene, however, doesn’t rule out the diagnosis of ichthyosis vulgaris or atopic dermatitis.

Negative (No mutants detected)

Polymerase chain reaction (PCR) followed by DNA sequence analysis, Next Generation Sequencing (NGS).

Whole blood, 3mL, EDTA.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
Skin biopsy.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login